Alpha Tau Medical Ltd. (NASDAQ: DRTS) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ALPHA TAU MEDICAL LTD.

Alpha Tau Medical Ltd. (NASDAQ: DRTS)
Listen to this Section


$9.32
-0.9750 ( -9.48% ) 836.4K

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.

Market Data


Open $9.32
Previous Close $10.29
Volume 836.4K
Market Cap $955.65M
Day Range $9.32 - $10.49
52 Week Range $2.81 - $11.62
Shares Outstanding 90.33M
Change % -9.48%
Net Change ▼ -0.9750
Insider Ownership N/A
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2022
CountryIsrael
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
144 Insider transactions 1 Nov 03, 2025
6-k Form 6-K 2 Oct 21, 2025
6-k Form 6-K 2 Sep 02, 2025
6-k Form 6-K 2 Aug 27, 2025
6-k Form 6-K 60 Aug 11, 2025
6-k Form 6-K 1 Jun 17, 2025

Latest News


× Before browsing our site, please accept our cookies policy